See more : The Tinley Beverage Company Inc. (TNYBF) Income Statement Analysis – Financial Results
Complete financial analysis of Jin Medical International Ltd. (ZJYL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jin Medical International Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Biogen Inc. (BIIB) Income Statement Analysis – Financial Results
- NG Energy International Corp. (GASXF) Income Statement Analysis – Financial Results
- Allied Digital Services Limited (ADSL.BO) Income Statement Analysis – Financial Results
- Sanwaria Consumer Limited (SANWARIA.NS) Income Statement Analysis – Financial Results
- Eco Buildings Group plc (ECOB.L) Income Statement Analysis – Financial Results
Jin Medical International Ltd. (ZJYL)
About Jin Medical International Ltd.
Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 19.82M | 19.19M | 20.76M | 16.19M | 20.37M | 20.91M |
| Cost of Revenue | 13.04M | 12.99M | 14.40M | 10.70M | 12.86M | 13.25M |
| Gross Profit | 6.78M | 6.20M | 6.36M | 5.50M | 7.51M | 7.66M |
| Gross Profit Ratio | 34.23% | 32.30% | 30.64% | 33.95% | 36.88% | 36.62% |
| Research & Development | 1.54M | 1.89M | 1.57M | 1.26M | 1.13M | 1.20M |
| General & Administrative | 1.92M | 1.77M | 1.67M | 1.50M | 1.60M | 1.72M |
| Selling & Marketing | 453.31K | 402.01K | 489.00K | 385.09K | 381.11K | 513.10K |
| SG&A | 2.37M | 2.18M | 2.16M | 1.88M | 1.98M | 2.23M |
| Other Expenses | 0.00 | 244.12K | 194.98K | 123.28K | 0.00 | 0.00 |
| Operating Expenses | 3.92M | 4.07M | 3.73M | 3.14M | 3.11M | 3.33M |
| Cost & Expenses | 16.95M | 17.06M | 18.13M | 13.84M | 15.96M | 16.59M |
| Interest Income | 0.00 | 181.61K | 0.00 | 0.00 | 0.00 | 25.24K |
| Interest Expense | 0.00 | 0.00 | 9.49K | 112.40K | 22.85K | 0.00 |
| Depreciation & Amortization | 225.90K | 357.27K | 341.25K | 324.93K | 344.04K | 368.26K |
| EBITDA | 3.09M | 3.10M | 3.23M | 2.79M | 4.49M | 4.60M |
| EBITDA Ratio | 15.61% | 12.02% | 15.28% | 17.34% | 23.31% | 21.98% |
| Operating Income | 2.87M | 2.13M | 2.63M | 2.35M | 4.40M | 4.23M |
| Operating Income Ratio | 14.47% | 11.10% | 12.67% | 14.54% | 21.62% | 20.22% |
| Total Other Income/Expenses | 354.68K | 612.11K | 248.85K | -1.52K | -276.61K | 71.02K |
| Income Before Tax | 3.22M | 2.74M | 2.88M | 2.35M | 4.13M | 4.30M |
| Income Before Tax Ratio | 16.25% | 14.29% | 13.87% | 14.53% | 20.26% | 20.56% |
| Income Tax Expense | 343.71K | 36.11K | 248.64K | 147.15K | 479.63K | 616.88K |
| Net Income | 2.88M | 2.71M | 2.63M | 2.21M | 3.65M | 3.68M |
| Net Income Ratio | 14.52% | 14.10% | 12.67% | 13.62% | 17.91% | 17.61% |
| EPS | 0.40 | 0.34 | 0.33 | 0.28 | 0.46 | 0.01 |
| EPS Diluted | 0.40 | 0.34 | 0.33 | 0.28 | 0.46 | 0.01 |
| Weighted Avg Shares Out | 7.26M | 8.00M | 8.00M | 8.00M | 8.00M | 400.01M |
| Weighted Avg Shares Out (Dil) | 7.26M | 8.00M | 8.00M | 8.00M | 8.00M | 400.00M |
Jin Medical International Limited (NASDAQ: ZJYL) Announces Financial Results for Six Months Ended March 31, 2023
JinMed (NASDAQ: ZJYL) Rings the Nasdaq Stock Market Closing Bell on August 17
JinMed's Nanobathing Products Receive Multiple Patent Certifications and Sign Directed Procurement Agreement with Shanghai Zhongjin HongKang Medical Technology
U.S. IPO Weekly Recap: Q1 IPO Market Wraps Up With 8 Foreign Issuers
Chinese Wheelchair Maker Tests U.S. Regulator's Appetite For Controversial VIE Structure
Source: https://incomestatements.info
Category: Stock Reports